Evidence map›Paper›PMID 32099435›Full record

ReviewClinical, cosmetic and investigational dermatology2019

Inverse Psoriasis: From Diagnosis to Current Treatment Options.

Giuseppe Micali, Anna Elisa Verzì, Giorgia Giuffrida, Enrico Panebianco, Maria Letizia Musumeci, Francesco Lacarrubba

Open access · goldAbstract readReview
In one paragraph

Review in Clinical, cosmetic and investigational dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Atrophic Areas on the Axillary and Anogenital Anatomy.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Unveiling Psoriasis: Delving into Pathogenesis, Treatment Breakthroughs, and Patent Trends.Recent advances in inflammation & allergy drug discovery · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Updates on Psoriasis in Special Areas.Journal of clinical medicine · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Giuseppe MicaliDermatology Clinic, University of Catania, Catania, Italy.ORCID 0000-0002-5157-3939
Anna Elisa VerzìDermatology Clinic, University of Catania, Catania, Italy.ORCID 0000-0002-3274-6099
Giorgia GiuffridaDermatology Clinic, University of Catania, Catania, Italy.
Enrico PanebiancoDermatology Clinic, University of Catania, Catania, Italy.
Maria Letizia MusumeciDermatology Clinic, University of Catania, Catania, Italy.
Francesco LacarrubbaDermatology Clinic, University of Catania, Catania, Italy.ORCID 0000-0002-0860-2060
University of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inverse psoriasis represents a clinical variant of psoriasis that is sometimes difficult to diagnose due to its clinical similarity with other skin disorders involving the folds, mainly including mechanical intertrigo, fungal and bacterial infections, contact dermatitis, seborrheic dermatitis, and lichen planus. Dermoscopy represents a useful tool for an enhanced non-invasive diagnosis. The treatment of inverse psoriasis may be challenging and include topical corticosteroids, topical calcineurin inhibitors, vitamin D analogs, traditional oral systemic therapies such as cyclosporine and methotrexate, and biologic therapies.

Indexed as

confocal microscopydermoscopydiagnosisinversepsoriasistreatment

Identifiers

PMID32099435
PMCPMC6997231
OpenAlexW2997434399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.